日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Modulating the PPARγ pathway upregulates NECTIN4 and enhances chimeric antigen receptor (CAR) T cell therapy in bladder cancer.

调节 PPARγ 通路可上调 NECTIN4,并增强嵌合抗原受体 (CAR) T 细胞疗法在膀胱癌中的疗效

Chang Kevin, Delavan Henry M, Yip Elizabeth, Kasap Corynn, Zhu Jun, Lodha Roshan, Liao Sheng-You, Berman Sarah C, Carretero-Gonzalez Alberto, Basar Merve, Gokturk Ozcan Gamze, Teo Min Yuen, Solit David B, Rosenberg Jonathan E, Al-Ahmadie Hikmat, Ding Cornelia C K, Chan Emily, Steri Veronica, Porten Sima P, Koshkin Vadim S, Friedlander Terence W, Feng Felix Y, Lee John K, Wiita Arun P, Chu Carissa E, Chou Jonathan

Clinical and Translational Results from PORTER, a Multicohort Phase I Platform Trial of Combination Immunotherapy in Metastatic Castration-Resistant Prostate Cancer

PORTER研究的临床和转化结果:一项针对转移性去势抵抗性前列腺癌的联合免疫疗法多队列I期平台试验

Galsky, Matthew D; Autio, Karen A; Cabanski, Christopher R; Wentzel, Kristopher; Graff, Julie N; Friedlander, Terence W; Howes, Timothy R; Shotts, Kristin M; Densmore, Julie; Spasic, Marko; Da Silva, Diane M; Chen, Richard O; Lata, Jennifer; Skolnik, Jeffrey; Keler, Tibor; Yellin, Michael J; LaVallee, Theresa M; Fairchild, Justin; Boffo, Silvia; O'Donnell-Tormey, Jill; Dugan, Ute; Bhardwaj, Nina; Subudhi, Sumit K; Fong, Lawrence

Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab

晚期尿路上皮癌患者(不适合接受顺铂治疗)接受一线恩福妥单抗单药治疗或联合帕博利珠单抗治疗的患者报告结局

Milowsky, Matthew I; O'Donnell, Peter H; Hoimes, Christopher J; Petrylak, Daniel P; Flaig, Thomas W; Moon, Helen H; Friedlander, Terence W; Mar, Nataliya; McKay, Rana R; Srinivas, Sandy; Gravis, Gwenaelle; Ramamurthy, Chethan; Bupathi, Manojkumar; Bracarda, Sergio; Wright, Phoebe; Hepp, Zsolt; Carret, Anne-Sophie; Yu, Yao; Dillon, Ryan; Kataria, Ritesh; Beaumont, Jennifer L; Purnajo, Intan; Rosenberg, Jonathan E

HER2 overexpression in urothelial carcinoma with GATA3 and PPARG copy number gains

尿路上皮癌中 HER2 过表达伴 GATA3 和 PPARG 拷贝数增加

Zhu, Xiaolin; Chan, Emily; Turski, Michelle L; Mendez, Carlos Espinosa; Hsu, Sarah C; Kumar, Vipul; Shipp, Chase; Jindal, Tanya; Chang, Kevin; Onodera, Courtney; Devine, W Patrick; Grenert, James P; Stohr, Bradley A; Ding, Chien-Kuang Cornelia; Stachler, Matthew D; Quigley, David A; Feng, Felix Y; Chu, Carissa E; Porten, Sima P; Chou, Jonathan; Friedlander, Terence W; Koshkin, Vadim S

Central Nervous System Disease Progression Among Patients With Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin: A Case Series

接受恩福妥单抗治疗的转移性尿路上皮癌患者中枢神经系统疾病进展:病例系列研究

Shipp, Chase; Jindal, Tanya; Chou, Jonathan; Friedlander, Terence W; Koshkin, Vadim S; Kumar, Vipul

A plain language summary exploring a new treatment combination for untreated locally advanced or metastatic urothelial cancer: enfortumab vedotin plus pembrolizumab

一份通俗易懂的摘要,探讨一种用于治疗未经治疗的局部晚期或转移性尿路上皮癌的新疗法组合:恩福妥单抗联合帕博利珠单抗

Hoimes, Christopher J; Flaig, Thomas W; Milowsky, Matthew I; Friedlander, Terence W; Bilen, Mehmet Asim; Gupta, Shilpa; Srinivas, Sandy; Merchan, Jaime R; McKay, Rana R; Petrylak, Daniel P; Sasse, Carolyn; Moreno, Blanca Homet; Yu, Yao; Carret, Anne-Sophie; Rosenberg, Jonathan E

Enfortumab Vedotin With or Without Pembrolizumab in Cisplatin-Ineligible Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer

恩福妥单抗联合或不联合帕博利珠单抗治疗既往未接受治疗的局部晚期或转移性尿路上皮癌患者(不适合顺铂治疗)

O'Donnell, Peter H; Milowsky, Matthew I; Petrylak, Daniel P; Hoimes, Christopher J; Flaig, Thomas W; Mar, Nataliya; Moon, Helen H; Friedlander, Terence W; McKay, Rana R; Bilen, Mehmet A; Srinivas, Sandy; Burgess, Earle F; Ramamurthy, Chethan; George, Saby; Geynisman, Daniel M; Bracarda, Sergio; Borchiellini, Delphine; Geoffrois, Lionnel; Maroto Rey, Jose Pablo; Ferrario, Christiano; Carret, Anne-Sophie; Yu, Yao; Guseva, Maria; Homet Moreno, Blanca; Rosenberg, Jonathan E

Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial Cancer

Enfortumab Vedotin 联合 Pembrolizumab 治疗既往未接受治疗的晚期尿路上皮癌

Hoimes, Christopher J; Flaig, Thomas W; Milowsky, Matthew I; Friedlander, Terence W; Bilen, Mehmet Asim; Gupta, Shilpa; Srinivas, Sandy; Merchan, Jaime R; McKay, Rana R; Petrylak, Daniel P; Sasse, Carolyn; Moreno, Blanca Homet; Yu, Yao; Carret, Anne-Sophie; Rosenberg, Jonathan E

TROP2 Expression Across Molecular Subtypes of Urothelial Carcinoma and Enfortumab Vedotin-resistant Cells

TROP2 在尿路上皮癌分子亚型和恩福妥单抗耐药细胞中的表达

Chou, Jonathan; Trepka, Kai; Sjöström, Martin; Egusa, Emily A; Chu, Carissa E; Zhu, Jun; Chan, Emily; Gibb, Ewan A; Badura, Michelle L; Contreras-Sanz, Alberto; Stohr, Bradley A; Meng, Maxwell V; Pruthi, Raj S; Lotan, Yair; Black, Peter C; Porten, Sima P; Koshkin, Vadim S; Friedlander, Terence W; Feng, Felix Y

Changes in older adults' life space during lung cancer treatment: A mixed methods cohort study

肺癌治疗期间老年人生活空间的变化:一项混合方法队列研究

Wong, Melisa L; Shi, Ying; Smith, Alexander K; Miaskowski, Christine; Boscardin, W John; Cohen, Harvey Jay; Lam, Vivian; Mazor, Melissa; Metzger, Lia; Presley, Carolyn J; Williams, Grant R; Loh, Kah Poh; Ursem, Carling J; Friedlander, Terence W; Blakely, Collin M; Gubens, Matthew A; Allen, Gregory; Shumay, Dianne; Walter, Louise C